Vidipha Central Pharmaceutical JSC

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000VDP2
VND
54,000.00
-900 (-1.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
1,95,923.71
1,56,839.00
3,58,641.46
2,25,110.18
2,10,306.13
3,07,727.81
2,13,464.82
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,95,923.71
1,56,839.00
3,58,641.46
2,25,110.18
2,10,306.13
3,07,727.81
2,13,464.82
Raw Material Cost
1,45,295.53
84,546.73
3,01,556.04
1,59,569.25
1,55,493.75
2,51,593.46
1,52,405.31
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
7,612.38
0.00
7,398.34
8,943.24
8,621.07
0.00
7,376.20
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2,257.41
2,336.72
3,135.14
2,485.22
2,489.70
3,639.34
4,052.40
Selling and Distribution Expenses
37,108.97
43,762.54
43,170.32
47,887.99
34,398.19
33,584.26
43,103.47
Other Expenses
-986.98
-233.67
-1,053.35
-1,142.85
-1,111.08
-363.93
-1,142.86
Total Expenditure (Excl Depreciation)
1,82,404.49
1,28,309.27
3,44,726.36
2,07,457.24
1,89,891.94
2,85,177.72
1,95,508.78
Operating Profit (PBDIT) excl Other Income
13519.2
28529.699999999997
13915.1
17652.9
20414.2
22550.100000000002
17956
Other Income
3,699.93
1,480.99
4,395.34
1,849.47
-90.78
10,602.08
5,708.55
Operating Profit (PBDIT)
24,638.81
43,337.93
23,984.75
21,820.91
27,838.58
46,464.63
29,299.99
Interest
2,257.41
2,336.72
3,135.14
2,485.22
2,489.70
3,639.34
4,052.40
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
50,628.18
72,292.27
57,085.42
65,540.93
54,812.38
56,134.35
61,059.51
Depreciation
7,422.02
13,327.21
5,674.31
3,459.50
7,528.30
13,312.47
5,635.41
Profit Before Tax
14,959.38
27,674.01
15,175.30
15,876.20
17,820.59
29,512.82
19,612.19
Tax
3,041.79
8,146.92
3,183.76
3,321.65
3,685.62
6,073.74
4,046.54
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
11,917.59
19,527.08
11,991.54
12,554.55
14,134.97
23,439.08
15,565.64
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
11,917.59
19,527.08
11,991.54
12,554.55
14,134.97
23,439.08
15,565.64
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
11,917.59
19,527.08
11,991.54
12,554.55
14,134.97
23,439.08
15,565.64
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
7,61,989.52
7,50,071.93
7,50,213.08
7,27,063.98
7,56,264.75
7,51,771.30
7,34,090.90
Earnings per share (EPS)
539.66
884.24
543.01
568.51
640.07
1061.39
704.86
Diluted Earnings per share
539.66
884.24
543.01
568.51
640.07
1061.39
704.86
Operating Profit Margin (Excl OI)
6.9%
18.19%
3.88%
7.34%
9.7%
7.33%
8.41%
Gross Profit Margin
11.42%
26.14%
5.81%
8.59%
12.05%
13.92%
11.83%
PAT Margin
6.08%
12.45%
3.34%
5.58%
6.72%
7.62%
7.29%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is -6.84% vs 4.38% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is -15.69% vs -19.46% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -25.03% vs -6.04% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is -9.33% vs -40.64% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of Vidipha Central Pharmaceutical JSC With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
1,95,923.71
0
1,95,923.71
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,95,923.71
0
1,95,923.71
Raw Material Cost
1,45,295.53
0
1,45,295.53
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
7,612.38
0
7,612.38
Power Cost
0
0
0.00
Manufacturing Expenses
2,257.41
0
2,257.41
Selling and Distribution Expenses
37,108.97
0
37,108.97
Other Expenses
-986.98
0.00
-986.98
Total Expenditure (Excl Depreciation)
1,82,404.49
0
1,82,404.49
Operating Profit (PBDIT) excl Other Income
13,519.22
0.00
13,519.22
Other Income
3,699.93
0
3,699.93
Operating Profit (PBDIT)
24,638.81
0
24,638.81
Interest
2,257.41
0
2,257.41
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
50,628.18
0
50,628.18
Depreciation
7,422.02
0
7,422.02
Profit Before Tax
14,959.38
0
14,959.38
Tax
3,041.79
0
3,041.79
Provisions and contingencies
0
0
0.00
Profit After Tax
11,917.59
0
11,917.59
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
11,917.59
0
11,917.59
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
11,917.59
0
11,917.59
Equity Capital
0
0
0.00
Face Value
10,000.00
0
0.00
Reserves
7,61,989.52
0
7,61,989.52
Earnings per share (EPS)
539.66
0
539.66
Diluted Earnings per share
539.66
0
539.66
Operating Profit Margin (Excl OI)
6.90%
0%
0.00
6.90%
Gross Profit Margin
11.42%
0%
0.00
11.42%
PAT Margin
6.08%
0%
0.00
6.08%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 19,592.37 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 24.92% vs -56.27% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -6.84% vs 4.38% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1,191.76 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -38.97% vs 62.84% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -15.69% vs -19.46% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2,093.89 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -49.98% vs 113.67% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -25.03% vs -6.04% in Mar 2025

Quarterly - Interest
Interest 225.74 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -3.39% vs -25.47% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -9.33% vs -40.64% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.90%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025